How are CYP1A2 and blood sugar related?

CYP1A2 is primarily known for metabolizing caffeine and certain drugs. A direct, well-established link between CYP1A2 variants and blood sugar levels is not supported by strong evidence. The connection is indirect: caffeine can transiently reduce insulin sensitivity and raise blood glucose. Since CYP1A2 determines caffeine clearance, 'slow metabolizers' (e.g., carriers of the -163C>A polymorphism) may retain caffeine longer and experience more pronounced glycemic fluctuations. However, effects are small, highly variable, and confounded by lifestyle factors (sleep, diet). Some studies suggest an association with type 2 diabetes risk, but findings are inconsistent. For individuals, direct blood glucose monitoring is more reliable than genetic inference. Caution: Do not base supplement or dietary changes solely on CYP1A2 status.